BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li M, Liu GT. Inhibition of Fas/FasL mRNA expression and TNF-α release in concanavalin A-induced liver injury in mice by bicyclol. World J Gastroenterol 2004; 10(12): 1775-1779 [PMID: 15188504 DOI: 10.3748/wjg.v10.i12.1775]
URL: https://www.wjgnet.com/1007-9327/full/v10/i12/1775.htm
Number Citing Articles
1
Zheng Huai Tan, Ling Hong Yu, Huai Lin Wei, Geng Tao Liu. The protective action of scutellarin against immunological liver injury induced by concanavalin A and its effect on pro-inflammatory cytokines in miceJournal of Pharmacy and Pharmacology 2007; 59(1): 115 doi: 10.1211/jpp.59.1.0015
2
Sultan Alqahtani, Ayman M. Mahmoud, José Luís García-Giménez. Gamma‐Glutamylcysteine Ethyl Ester Protects against Cyclophosphamide‐Induced Liver Injury and Hematologic Alterations via Upregulation of PPARγ and Attenuation of Oxidative Stress, Inflammation, and ApoptosisOxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/4016209
3
Wenjun Shang, Yonghua Feng, Jinfeng Li, Xinzhou Wang, Hongchang Xie, Guiwen Feng. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantationOpen Medicine 2017; 12(1): 62 doi: 10.1515/med-2017-0012
4
Águeda González-Rodríguez, Bjorn Reibert, Thomas Amann, Rainier Constien, Cristina M. Rondinone, Ángela M. Valverde. In vivosiRNA delivery of Keap1 modulates death and survival signaling pathways and attenuates Concanavalin A-induced acute liver injury in miceDisease Models & Mechanisms 2014;  doi: 10.1242/dmm.015537
5
M. V. Maevskaya, V. D. Lunkov, N. I. Geyvandova, L. K. Palgova, I. Yu. Pirogova, M. K. Prashnova, N. V. Marchenko, E. N. Zinovieva, T. A. Ilchishina, V. T. Ivashkin, P. V. Koroy. Bicyclol in the treatment of patients with chronic diffuse liver diseasesMeditsinskiy sovet = Medical Council 2020; (15): 78 doi: 10.21518/2079-701X-2020-15-78-89
6
Hua Sun, Linghong Yu, Huailing Wei, Gengtao Liu. A Novel Antihepatitis Drug, Bicyclol, Prevents Liver Carcinogenesis in Diethylnitrosamine-Initiated and Phenobarbital-Promoted Mice Tumor ModelJournal of Biomedicine and Biotechnology 2012; 2012: 1 doi: 10.1155/2012/584728
7
Hua Sun, Geng-Tao Liu. Inhibitory effect of anti-hepatitis drug bicyclol on invasion of human hepatocellular carcinoma MHCC97-H cells with high metastasis potential and its relative mechanismsJournal of Asian Natural Products Research 2009; 11(6): 576 doi: 10.1080/10286020902942368
8
Ying-Nan Yu, Hui Chen, Yan Li. Protect effect of bicyclol on cisplatin-induced nephrotoxicity in miceArchives of Toxicology 2009; 83(4): 381 doi: 10.1007/s00204-008-0370-2
9
Hongxue Li, Qian Xu, Chengye Xu, Yuxin Hu, Xingyang Yu, Kangqi Zhao, Mingqing Li, Meng Li, Junfang Xu, Hongyu Kuang. Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting InflammationFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.644129
10
Yong-Zhan Zhen, Na-Ren Li, Hong-Wei He, Shuang-Shuang Zhao, Guang-Ling Zhang, Xiao-Fang Hao, Rong-Guang Shao. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in ratsWorld Journal of Gastroenterology 2015; 21(23): 7155-7164 doi: 10.3748/wjg.v21.i23.7155
11
Qing-Wei Hu, Geng-Tao Liu. Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of actionLife Sciences 2006; 79(6): 606 doi: 10.1016/j.lfs.2006.02.025
12
Si-Yuan Pan, Hang Dong, Zhi-Ling Yu, Xin-Ye Zhao, Chun-Jing Xiang, Hui Wang, Wang-Fun Fong, Kam-Ming Ko. Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic miceJournal of Pharmacy and Pharmacology 2007; 59(12): 1657 doi: 10.1211/jpp.59.12.0007
13
Hui-Juan Dai, Da-Wei Li, Ya-Xiang Wang, Ai-Jun Sun, Yi-Xian Lu, Xin- Ding, Ming- Zhang, Yong-Gang Song, Xuan-Dong Huang. Induction of heat shock protein 27 by bicyclol attenuates d-galactosamine/lipopolysaccharide-induced liver injuryEuropean Journal of Pharmacology 2016; 791: 482 doi: 10.1016/j.ejphar.2016.09.002
14
Courtney M. Lappas , Yuan-Ji Day , Melissa A. Marshall , Victor H. Engelhard , Joel Linden . Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation The Journal of Experimental Medicine 2006; 203(12): 2639 doi: 10.1084/jem.20061097
15
Xucong Huang, Mengqi Jia, Yanchao Liu, Shuowen Wang, Yuanjun Tang, Xiaojing Li, Xinhui Jiang, Zhenghua Wu, Yuefen Lou, Guorong Fan. Identification of bicyclol metabolites in rat plasma, urine and feces by UPLC-Q-TOF-MS/MS and evaluation of the efficacy and safety of these metabolites based on network pharmacology and molecular docking combined with toxicity predictionJournal of Pharmaceutical and Biomedical Analysis 2022; 220: 114947 doi: 10.1016/j.jpba.2022.114947
16
Edwina S. Baskin-Bey, Wendong Huang, Norihisa Ishimura, Hajime Isomoto, Steven F. Bronk, Karen Braley, Ruth W. Craig, David D. Moore, Gregory J. Gores. Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteinsHepatology 2006; 44(1): 252 doi: 10.1002/hep.21236
17
V. T. Ivashkin, K. L. Raikhelson, L. K. Palgova, M. V. Maevskaya, O. A. Gerasimova, E. A. Kondrashina, N. V. Marchenko, A. Yu. Baranovsky. Drug-induced liver injury in cancer patientsOncohematology 2020; 15(3): 80 doi: 10.17650/1818-8346-2020-15-3-80-94
18
Shu Jia, Lianyu Jin, Xiaoyan Cheng, Jingyi Wu, Xiaokun Yao, Jingping Shao, Congcong Zhang, Danwei Cen, Bin Cheng, Jing Wang, Lei Chen, Xiaomin Yao. Bicyclol alleviates high-fat diet-induced hepatic ER stress- and autophagy-associated non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in miceDrug Development and Industrial Pharmacy 2022; 48(6): 247 doi: 10.1080/03639045.2022.2106238
19
Ming-Wei Wang, Xiaojiang Hao, Kaixian Chen. Biological screening of natural products and drug innovation in ChinaPhilosophical Transactions of the Royal Society B: Biological Sciences 2007; 362(1482): 1093 doi: 10.1098/rstb.2007.2036
20
Ying‐Nan Yu, Hui Chen, Yan Li. Effect of Bicyclol on Cisplatin‐Induced Hepatotoxicity in the Hepatocarcinoma 22 Tumour‐Bearing MiceBasic & Clinical Pharmacology & Toxicology 2009; 104(4): 300 doi: 10.1111/j.1742-7843.2008.00343.x
21
K Wang. Molecular mechanisms of hepatic apoptosisCell Death & Disease 2014; 5(1): e996 doi: 10.1038/cddis.2013.499
22
Haidan Yuan, Qianqian Ma, Li Ye, Guangchun Piao. The Traditional Medicine and Modern Medicine from Natural ProductsMolecules 2016; 21(5): 559 doi: 10.3390/molecules21050559
23
Cancer Biology and Advances in TreatmentAdvances in Experimental Medicine and Biology 2020; 1292: 157 doi: 10.1007/5584_2020_525
24
Ayman M. Mahmoud, Omnia E. Hussein, Walaa G. Hozayen, Sanaa M. Abd El-Twab. Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARγ and Nrf2: Protective effect of 18β-Glycyrrhetinic acidChemico-Biological Interactions 2017; 270: 59 doi: 10.1016/j.cbi.2017.04.009
25
Jianzuo Yao, Jingyi Wu, Shu Jia, Jingping Shao, Xie Zhang, Zeping Xu, Hui Zhang, Hong Li, Xiaomin Yao. Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetumJournal of Clinical Laboratory Analysis 2022; 36(12) doi: 10.1002/jcla.24793
26
Vladimir T. Ivashkin, Andrey Yu. Baranovsky, Karina L. Raikhelson, Lyudmila K. Palgova, Marina V. Maevskaya, Elina A. Kondrashina, Natalya V. Marchenko, Tatyana P. Nekrasova, Igor G. Nikitin. Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)Russian Journal of Gastroenterology, Hepatology, Coloproctology 2019; 29(1): 101 doi: 10.22416/1382-4376-2019-29-1-101-131
27
Wen Xie, Guangfeng Shi, Hongfei Zhang, Guiming Zhao, Zujiang Yu, Zhenwei Lang, Hong Zhao, Jie Yan, Jun Cheng. A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclolHepatology International 2012; 6(2): 441 doi: 10.1007/s12072-011-9294-7
28
I. Yu. Pirogova, S. V. Yakovleva, T. V. Neuymina, S. P. Sinitsyn, V. S. Chulkov, T. N. Shamaeva. Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort StudyRossijskij žurnal gastroènterologii gepatologii koloproktologii 2018; 28(4): 66 doi: 10.22416/1382-4376-2018-28-4-66-75
29
Sunil Kumar Verma, Minakshi Pandey, Avinash Sharma, Devendra Singh. Exploring Ayurveda: principles and their application in modern medicineBulletin of the National Research Centre 2024; 48(1) doi: 10.1186/s42269-024-01231-0
30
Tianming Zhao, Lihong Mao, Zihan Yu, Yangyang Hui, Hongjuan Feng, Xiaoyu Wang, Lin Lin, Xiaofei Fan, Xin Chen, Bangmao Wang, Xiaocang Cao, Chao Sun. Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicineInternational Immunopharmacology 2021; 91: 107308 doi: 10.1016/j.intimp.2020.107308
31
Hua Sun, Geng-Tao Liu. Chemopreventive effect of bicyclol on malignant transformation of WB-F344 rat liver epithelial cells and its effect on related signal transduction in vitroCancer Letters 2006; 236(2): 239 doi: 10.1016/j.canlet.2005.05.019
32
Xiu-Qi Bao, Geng-Tao Liu. Induction of Overexpression of the 27- and 70-kDa Heat Shock Proteins by Bicyclol Attenuates Concanavalin A-Induced Liver Injury through Suppression of Nuclear Factor-κB in MiceMolecular Pharmacology 2009; 75(5): 1180 doi: 10.1124/mol.108.053280
33
Yan Hou, Libo Li, Huailing Wei, Liping Wu, Yuanfeng Tong, Song Wu, Gengtao Liu. Protection by bicyclol derivatives against acetaminophen‐induced acute liver failure in mice and its active mechanismLiver International 2008; 28(9): 1226 doi: 10.1111/j.1478-3231.2008.01757.x